PURA - Puration Inc Garners Interest From $330 Billion Beverage Industry Brand Name Players
October 11 2018 - 9:10AM
InvestorsHub Cannabis NewsWire
Dallas, TX -- October 11, 2018 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) today released an online management presentation to
provide more detail on its corporate restructuring to concentrate
resources on its rapidly expanding cannabis infused beverage
business. The presentation includes details on the recently
announced spinoff of its cannabis cultivation business and the
pending dividend distribution of spinoff stock. The
presentation also includes details on the company’s current two
cannabis infused beverages and the recently announced letter of
intent to acquire a company with a third cannabis sector
beverage. The presentation highlights the company’s overall
strategy to optimize the movement of major brand name beverage
industry players into the cannabis sector in addition to reporting
recent interest shown by some brand name players into Puration’s
experience in the cannabis infused beverage sector. View the
presentation on the company’s website or read the
narrative from the presentation included in its entirety
below:
Puration Cannabis Infused Beverage Industry
Restructuring Strategy
Presentation
Major beverage industry players are jockeying
for position in the nascent cannabis infused beverage market.
Canada’s legalization of recreational
marijuana, which goes into effect next week, triggered
Fortune 500 sized interest in the cannabis sector. Up until
Canada’s vote to legalize recreational marijuana, large
corporations and investment houses remained on the sidelines. Now
Corona Beer parent Constellation
Brands has jumped in to the cannabis sector making a
$4 billion investment. Coca-Cola is “eyeing” the CBD sector
and Molson Coors Brewing Co. has announced
a partnership to develop a non-alcoholic cannabis infused beverage
for the Canadian market. Soft drink sales in the U.S. total
$112 billion annually and alcohol
beverage sales in the U.S. total $223 billion.
With such household brand names in an industry
producing over $330 billion in sales annually now taking interest
in cannabis infused beverages, Puration finds itself in an enviable
position having not only already developed and produced a cannabis
infused beverage, but also having earned over a year’s worth of
hard knocks experience marketing and distributing its cannabis
infused beverages. Puration’s cannabis infused beverages are
on shelves in sports nutrition retailers, liquor stores and
dispensaries. The company’s experience has of late attracted
the attention of some beverage industry heavyweights and with
reaching the $1 million in annual sales benchmark now on a not too
distant horizon, that interest could potentially grow into a more
committed relationship. Look for an upcoming interview of
Puration CEO Brian Shibley to be published next week to learn more
about the recent interest in Puration’s cannabis infused beverage
experience.
Puration’s 600% Cannabis Infused Beverage Sales
Growth Experience
Puration debuted its EVERx CBD Sports Water
early last year at Arnold Schwarzenegger’s Arnold Sports
Festival. EVERx has since become the leading CBD infused
beverage in the sports nutrition marketplace. The company
reported 600% sales growth in the second quarter of this year and
recently announced a $1 million annual revenue benchmark being
potentially within reach for 2018. The company has its first
THC infused beverage, THCSavor, under development and has recently
announced a letter of intent to acquire a company with a third
cannabis sector beverage. The acquisition is anticipated to
be completed later this month.
Puration’s History From Cannabis Extraction
Patent To Beverage Producer
Puration entered the cannabis sector when it
acquired the rights to a patented cannabis extraction process from
North American Cannabis Holdings, Inc. (USMJ). The
entrepreneurial business plan has evolved since the acquisition
with the company now concentrating its cannabis sector expertise
and experience exclusively on the production of cannabis infused
beverages. Today, the company maintains its patented cannabis
extraction license as part of its strategy to produce
differentiated cannabis infused
beverages.
Puration’s Cannabis Cultivation
Spinoff
To
streamline and concentrate all its resources on the production of
cannabis infused beverages, Puration has recently spun-off its
cannabis cultivation operation. The spinoff was affected
through the execution of a securities exchange agreement with
Nouveau Life Pharmaceuticals, Inc., (NOUV) (“NOUV”). Puration
sold its cannabis cultivation business in exchange for a
convertible purchase note issued by NOUV. Puration and NOUV
have agreed to a recapitalization plan for NOUV and a post
recapitalization conversion of the purchase note into a number of
common NOUV shares sufficient to issue one NOUV common share for
every five shares of Puration common shares issued and
outstanding. All of the NOUV common shares issued in
conversion of the purchase note are slated for distributed to
Puration shareholders in a dividend distribution. Look for a
presentation coming soon from NOUV on its business plans for the
cannabis cultivation business.
Puration’s Pending Stock Dividend
Distribution
Now
that the securities exchange agreement between NOUV and Puration is
finalized, NOUV is working to rapidly come current with its
financial reports. Once NOUV is current, the company will
initiate a recapitalization. Following the recapitalization,
the purchase note will be converted into NOUV common shares and
Puration will initiate the necessary steps to issue the converted
NOUV shares to Puration shareholders through a dividend
distribution. The first steps leading to the stock dividend
distribution are underway, and the combined management teams are
committed to a prompt delivery of the planed stock
dividend.
Goldman Small Cap Puration Research Report:
Speculative-Buy and Target $0.25
PPS
Goldman
Small Cap Research issued a research report on Puration, Inc.
published October 10, 2018. The report includes a 'speculative-buy'
rating with a target price-per-share of $0.25. The report
provides an in-depth overview and analysis of Puration's successes,
approach, new initiatives, and upcoming milestones. To view the
report, along with disclosures and disclaimers,
visit http://www.GoldmanResearch.com or https://www.purationinc.com/goldman-research/.
Learn more about Puration at www.purationinc.com
Disclaimer/Safe
Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Sep 2023 to Sep 2024